These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3731152

  • 1. Differential drug sensitivity of human neuroblastoma cells.
    Spengler BA, Ross RA, Biedler JL.
    Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo preclinical chemotherapy studies of human neuroblastoma.
    Siegel MM, Chung HS, Rucker N, Siegel SE, Seeger RC, Isaacs H, Benedict WF.
    Cancer Treat Rep; 1980 Aug; 64(8-9):975-9. PubMed ID: 7448832
    [Abstract] [Full Text] [Related]

  • 3. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC.
    Cancer Res; 1993 Oct 15; 53(20):4978-86. PubMed ID: 8402688
    [Abstract] [Full Text] [Related]

  • 4. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.
    Preis PN, Saya H, Nádasdi L, Hochhaus G, Levin V, Sadée W.
    Cancer Res; 1988 Nov 15; 48(22):6530-4. PubMed ID: 2846152
    [Abstract] [Full Text] [Related]

  • 5. Adrenergic, cholinergic, and inactive human neuroblastoma cell lines with the action-potential Na+ ionophore.
    West GJ, Uki J, Herschman HR, Seeger RC.
    Cancer Res; 1977 May 15; 37(5):1372-6. PubMed ID: 15722
    [Abstract] [Full Text] [Related]

  • 6. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC, Sandoval JA, Klein PJ, Woodruff HA, Grosfeld JL, Hickey RJ, Malkas LH, Schmidt CM.
    J Pediatr Surg; 2006 Jan 15; 41(1):252-9. PubMed ID: 16410143
    [Abstract] [Full Text] [Related]

  • 7. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A, Zintl F.
    Med Pediatr Oncol; 2003 Apr 15; 40(4):205-13. PubMed ID: 12555246
    [Abstract] [Full Text] [Related]

  • 8. Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines.
    Seeger RC, Rayner SA, Banerjee A, Chung H, Laug WE, Neustein HB, Benedict WF.
    Cancer Res; 1977 May 15; 37(5):1364-71. PubMed ID: 856461
    [Abstract] [Full Text] [Related]

  • 9. Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines.
    Ireland CM, Pittman SM, Jones SL, Harnett PR.
    Anticancer Res; 1994 May 15; 14(6B):2397-403. PubMed ID: 7872659
    [Abstract] [Full Text] [Related]

  • 10. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues.
    Sano K, Nakamura H, Mabuchi S, Tanaka T, Nakagawara A, Takai Y.
    Cancer Res; 1990 Nov 15; 50(22):7242-5. PubMed ID: 2121331
    [Abstract] [Full Text] [Related]

  • 11. Differential sensitivity of human neuroblastoma cell lines to ethanol: correlations with their proliferative responses to mitogenic growth factors and expression of growth factor receptors.
    Luo J, Miller MW.
    Alcohol Clin Exp Res; 1997 Oct 15; 21(7):1186-94. PubMed ID: 9347077
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta 1 differentially regulates proliferation, morphology, and extracellular matrix expression by three neural crest-derived neuroblastoma cell lines.
    Rogers SL, Cutts JL, Gegick PJ, McGuire PG, Rosenberger C, Krisinski S.
    Exp Cell Res; 1994 Apr 15; 211(2):252-62. PubMed ID: 8143771
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
    Bruchelt G, Girgert R, Buck J, Wolburg H, Niethammer D, Treuner J.
    Cancer Res; 1988 Jun 01; 48(11):2993-7. PubMed ID: 3365688
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: correlation with expression of growth factors and growth factor receptors.
    Janet T, Lüdecke G, Otten U, Unsicker K.
    J Neurosci Res; 1995 Apr 15; 40(6):707-15. PubMed ID: 7629887
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
    Strickland DK, Vaidyanathan G, Zalutsky MR.
    Cancer Res; 1994 Oct 15; 54(20):5414-9. PubMed ID: 7923174
    [Abstract] [Full Text] [Related]

  • 16. Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells.
    Meyers MB, Shen WP, Spengler BA, Ciccarone V, O'Brien JP, Donner DB, Furth ME, Biedler JL.
    J Cell Biochem; 1988 Oct 15; 38(2):87-97. PubMed ID: 2464605
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
    Slade RF, Hunt DA, Pochet MM, Venema VJ, Hennigar RA.
    Anticancer Res; 2003 Oct 15; 23(2B):1235-43. PubMed ID: 12820377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.